Skip to main content

Animations

MJFF Publications

6031 - 6040 of 6617 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2022
  • 2023
  • 2023
  • 2021
  • 2022
  • Summary Details
    OPEN
    Title: Bach1 derepression is neuroprotective in a mouse model of Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2111643118
    Citation Count: 82
  • Summary Details
    OPEN
    Title: Temporal proteomics during neurogenesis reveals large-scale proteome and organelle remodeling via selective autophagy
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.molcel.2021.10.001
    Citation Count: 102
  • Summary Details
    OPEN
    Title: [18F]Nifene PET/CT Imaging in Mice: Improved Methods and Preliminary Studies of α4β2* Nicotinic Acetylcholinergic Receptors in Transgenic A53T Mouse Model of α-Synucleinopathy and Post-Mortem Human Parkinson’s Disease
    Journal Name: Molecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/molecules26237360
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Rapid Dynamic Naturalistic Monitoring of Bradykinesia in Parkinson’s Disease Using a Wrist-Worn Accelerometer
    Journal Name: Sensors
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/s21237876
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissue
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-27204-9
    Citation Count: 61
  • Summary Details
    OPEN
    Title: Substitution of PINK1 Gly411 modulates substrate receptivity and turnover
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/15548627.2022.2151294
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Lifestyle factors and clinical severity of Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-31531-w
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-023-02585-x
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Cellular Bioenergetics and AMPK and TORC1 Signalling in Blood Lymphoblasts Are Biomarkers of Clinical Status in FMR1 Premutation Carriers
    Journal Name: Frontiers in Psychiatry
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fpsyt.2021.747268
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2021.110090
    Citation Count: 93
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.